LSA
L & S Advisors’s Fate Therapeutics FATE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-24,946
| Closed | -$559K | – | 249 |
|
|
2022
Q3 | $559K | Buy |
+24,946
| New | +$559K | 0.1% | 159 |
|
|
2022
Q1 | – | Sell |
-25,513
| Closed | -$1.49M | – | 295 |
|
|
2021
Q4 | $1.49M | Buy |
25,513
+8,414
| +49% | +$492K | 0.16% | 151 |
|
|
2021
Q3 | $1.01M | Sell |
17,099
-5,548
| -24% | -$329K | 0.11% | 193 |
|
|
2021
Q2 | $1.97M | Buy |
22,647
+503
| +2% | +$43.7K | 0.21% | 147 |
|
|
2021
Q1 | $1.83M | Sell |
22,144
-2,375
| -10% | -$196K | 0.21% | 155 |
|
|
2020
Q4 | $2.23M | Sell |
24,519
-2,602
| -10% | -$237K | 0.26% | 135 |
|
|
2020
Q3 | $1.08M | Buy |
27,121
+4,879
| +22% | +$195K | 0.15% | 186 |
|
|
2020
Q2 | $763K | Buy |
22,242
+4,012
| +22% | +$138K | 0.11% | 193 |
|
|
2020
Q1 | $405K | Buy |
+18,230
| New | +$405K | 0.08% | 186 |
|